Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Bo Yu, Delong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00902-5 |
Similar Items
-
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
by: Bo Yu, et al.
Published: (2019-09-01) -
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01) -
Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia
by: Bo Yu, et al.
Published: (2019-10-01) -
Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
by: Delong Liu, et al.
Published: (2019-02-01) -
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
by: Gregorio Barilà, et al.
Published: (2021-01-01)